Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Intermediate prognosis in metastatic germ cell tumours-outcome and prognostic factors.

Seidel C, Daugaard G, Tryakin A, Necchi A, Cohn Cedermark G, Ståhl O, Hentrich M, Brito M, Albany C, Taza F, Gerl A, Oechsle K, Bokemeyer C.

Eur J Cancer. 2018 May;94:16-25. doi: 10.1016/j.ejca.2018.01.113. Epub 2018 Mar 20.

PMID:
29505967
2.

High risk of hypogonadism in young male cancer survivors.

Isaksson S, Bogefors K, Ståhl O, Eberhard J, Giwercman YL, Leijonhufvud I, Link K, Øra I, Romerius P, Bobjer J, Giwercman A.

Clin Endocrinol (Oxf). 2018 Mar;88(3):432-441. doi: 10.1111/cen.13534. Epub 2018 Jan 10.

PMID:
29245176
3.

Prematurity and neonatal outcome including congenital malformations after maternal malignancy within six months prior to or during pregnancy.

Sabeti Rad Z, Friberg B, Henic E, Rylander L, Ståhl O, Källén B, Lingman G.

Acta Obstet Gynecol Scand. 2017 Nov;96(11):1357-1364. doi: 10.1111/aogs.13197. Epub 2017 Sep 14.

PMID:
28777448
4.

Characteristics of the Offspring of Women with a History of Malignancy, Excluding Congenital Malformations.

Sabeti Rad Z, Friberg B, Henic E, Rylander L, Ståhl O, Källén B, Lingman G.

J Obstet Gynaecol Can. 2016 Nov;38(11):1037-1044. doi: 10.1016/j.jogc.2016.07.001. Epub 2016 Aug 23.

PMID:
27969558
5.

Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.

Fischer S, Tandstad T, Wheater M, Porfiri E, Fléchon A, Aparicio J, Klingbiel D, Skrbinc B, Basso U, Shamash J, Lorch A, Dieckmann KP, Cohn-Cedermark G, Ståhl O, Chau C, Arriola E, Marti K, Hutton P, Laguerre B, Maroto P, Beyer J, Gillessen S.

J Clin Oncol. 2017 Jan 10;35(2):194-200. Epub 2016 Nov 28.

6.

Congenital malformations in offspring of women with a history of malignancy.

Sabeti Rad Z, Friberg B, Henic E, Rylander L, Ståhl O, Källén B, Lingman G.

Birth Defects Res. 2017 Feb 15;109(3):224-233. doi: 10.1002/bdra.23584.

PMID:
27875028
7.

Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment.

Bogefors K, Giwercman YL, Eberhard J, Stahl O, Cavallin-Stahl E, Cohn-Cedermark G, Arver S, Giwercman A.

Asian J Androl. 2017 Sep-Oct;19(5):538-542. doi: 10.4103/1008-682X.191126.

8.

Deliveries After Malignant Disease Before Pregnancy: Maternal Characteristics, Pregnancy, and Delivery Complications.

Sabeti Rad Z, Friberg B, Henic E, Rylander L, Ståhl O, Källén B, Lingman G.

J Adolesc Young Adult Oncol. 2016 Sep;5(3):240-7. doi: 10.1089/jayao.2016.0008. Epub 2016 Apr 25.

PMID:
27111543
9.

Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA).

Tandstad T, Ståhl O, Dahl O, Haugnes HS, Håkansson U, Karlsdottir Å, Kjellman A, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Stierner U, Cavallin-Ståhl E, Wahlqvist R, Wall N, Cohn-Cedermark G; SWENOTECA.

Ann Oncol. 2016 Jul;27(7):1299-304. doi: 10.1093/annonc/mdw164. Epub 2016 Apr 6.

PMID:
27052649
10.

The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway.

Tandstad T, Ståhl O, Håkansson U, Wahlqvist R, Klepp O, Cavallin-Ståhl E, Cohn-Cedermark G; SWENOTECA.

Scand J Urol. 2016;50(1):9-13. doi: 10.3109/21681805.2015.1059360. Epub 2015 Jun 26.

PMID:
26116316
11.

Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience.

Cohn-Cedermark G, Stahl O, Tandstad T; SWENOTECA.

Andrology. 2015 Jan;3(1):102-10. doi: 10.1111/andr.280. Epub 2014 Oct 1. Review.

12.

Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.

Tandstad T, Solberg A, Håkansson U, Stahl O, Haugnes HS, Oldenburg J, Dahl O, Kjellman A, Angelsen A, Cohn-Cedermark G; SWENOTECA.

Acta Oncol. 2015 Apr;54(4):493-9. doi: 10.3109/0284186X.2014.953256. Epub 2014 Sep 5.

PMID:
25192551
13.

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group.

Tandstad T, Ståhl O, Håkansson U, Dahl O, Haugnes HS, Klepp OH, Langberg CW, Laurell A, Oldenburg J, Solberg A, Söderström K, Cavallin-Ståhl E, Stierner U, Wahlquist R, Wall N, Cohn-Cedermark G; SWENOTECA.

Ann Oncol. 2014 Nov;25(11):2167-72. doi: 10.1093/annonc/mdu375. Epub 2014 Aug 11.

PMID:
25114021
14.

Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer.

Isaksson S, Eberhard J, Ståhl O, Cavallin-Ståhl E, Cohn-Cedermark G, Arver S, Lundberg Giwercman Y, Giwercman A.

Andrology. 2014 Mar;2(2):252-8. doi: 10.1111/j.2047-2927.2014.00182.x. Epub 2014 Feb 12.

15.

Djeen (Database for Joomla!'s Extensible Engine): a research information management system for flexible multi-technology project administration.

Stahl O, Duvergey H, Guille A, Blondin F, Vecchio AD, Finetti P, Granjeaud S, Vigy O, Bidaut G.

BMC Res Notes. 2013 Jun 6;6:223. doi: 10.1186/1756-0500-6-223.

16.

Association between polymorphisms in the aryl hydrocarbon receptor repressor gene and disseminated testicular germ cell cancer.

Brokken LJ, Lundberg-Giwercman Y, Rajpert-De Meyts E, Eberhard J, Ståhl O, Cohn-Cedermark G, Daugaard G, Arver S, Giwercman A.

Front Endocrinol (Lausanne). 2013 Feb 14;4:4. doi: 10.3389/fendo.2013.00004. eCollection 2013.

17.

Mimicry of human sepsis in a rat model--prospects and limitations.

Stahl O, Löffler B, Haier J, Mardin WA, Mees ST.

J Surg Res. 2013 Jan;179(1):e167-75. doi: 10.1016/j.jss.2012.01.042. Epub 2012 Apr 1.

PMID:
22482762
18.

Association of polymorphisms in genes encoding hormone receptors ESR1, ESR2 and LHCGR with the risk and clinical features of testicular germ cell cancer.

Brokken LJ, Lundberg-Giwercman Y, Rajpert De-Meyts E, Eberhard J, Ståhl O, Cohn-Cedermark G, Daugaard G, Arver S, Giwercman A.

Mol Cell Endocrinol. 2012 Apr 4;351(2):279-85. doi: 10.1016/j.mce.2011.12.018. Epub 2012 Jan 5.

PMID:
22245602
19.

Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.

Olofsson SE, Tandstad T, Jerkeman M, Dahl O, Ståhl O, Klepp O, Bremnes RM, Cohn-Cedermark G, Langberg CW, Laurell A, Solberg A, Stierner U, Wahlqvist R, Wijkström H, Anderson H, Cavallin-Ståhl E.

J Clin Oncol. 2011 May 20;29(15):2032-9. doi: 10.1200/JCO.2010.29.1278. Epub 2011 Apr 11.

PMID:
21482994
20.

Risk of birth abnormalities in the offspring of men with a history of cancer: a cohort study using Danish and Swedish national registries.

Ståhl O, Boyd HA, Giwercman A, Lindholm M, Jensen A, Kjær SK, Anderson H, Cavallin-Ståhl E, Rylander L.

J Natl Cancer Inst. 2011 Mar 2;103(5):398-406. doi: 10.1093/jnci/djq550. Epub 2011 Feb 8.

21.

Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.

Tandstad T, Smaaland R, Solberg A, Bremnes RM, Langberg CW, Laurell A, Stierner UK, Ståhl O, Cavallin-Ståhl EK, Klepp OH, Dahl O, Cohn-Cedermark G.

J Clin Oncol. 2011 Feb 20;29(6):719-25. doi: 10.1200/JCO.2010.30.1044. Epub 2011 Jan 4.

PMID:
21205748
22.

Polymorphic variation in the androgen receptor gene: association with risk of testicular germ cell cancer and metastatic disease.

Västermark Å, Giwercman YL, Hagströmer O, Rajpert De-Meyts E, Eberhard J, Ståhl O, Cedermark GC, Rastkhani H, Daugaard G, Arver S, Giwercman A.

Eur J Cancer. 2011 Feb;47(3):413-9. doi: 10.1016/j.ejca.2010.08.017. Epub 2010 Sep 27.

PMID:
20880698
23.

Sperm DNA integrity in men treated for childhood cancer.

Romerius P, Ståhl O, Moëll C, Relander T, Cavallin-Ståhl E, Gustafsson H, Löfvander Thapper K, Jepson K, Spanò M, Wiebe T, Lundberg Giwercman Y, Giwercman A.

Clin Cancer Res. 2010 Aug 1;16(15):3843-50. doi: 10.1158/1078-0432.CCR-10-0140. Epub 2010 Jun 2.

24.

High risk of azoospermia in men treated for childhood cancer.

Romerius P, Ståhl O, Moëll C, Relander T, Cavallin-Ståhl E, Wiebe T, Giwercman YL, Giwercman A.

Int J Androl. 2011 Feb;34(1):69-76. doi: 10.1111/j.1365-2605.2010.01058.x.

PMID:
20345878
25.

Hypogonadism risk in men treated for childhood cancer.

Romerius P, Ståhl O, Moëll C, Relander T, Cavallin-Ståhl E, Wiebe T, Giwercman YL, Giwercman A.

J Clin Endocrinol Metab. 2009 Nov;94(11):4180-6. doi: 10.1210/jc.2009-0337. Epub 2009 Sep 29.

PMID:
19789207
26.

Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality.

Eberhard J, Ståhl O, Cohn-Cedermark G, Cavallin-Ståhl E, Giwercman Y, Rastkhani H, Rylander L, Eberhard-Gran M, Kvist U, Giwercman A.

J Affect Disord. 2010 May;122(3):260-6. doi: 10.1016/j.jad.2009.06.035. Epub 2009 Aug 4.

PMID:
19656574
27.

Sexual function in men treated for testicular cancer.

Eberhard J, Ståhl O, Cohn-Cedermark G, Cavallin-Ståhl E, Giwercman Y, Rylander L, Eberhard-Gran M, Kvist U, Fugl-Meyer KS, Giwercman A.

J Sex Med. 2009 Jul;6(7):1979-89. doi: 10.1111/j.1743-6109.2009.01298.x. Epub 2009 Apr 28.

PMID:
19453896
28.

Sperm DNA integrity in cancer patients: the effect of disease and treatment.

Ståhl O, Eberhard J, Cavallin-Ståhl E, Jepson K, Friberg B, Tingsmark C, Spanò M, Giwercman A.

Int J Androl. 2009 Dec;32(6):695-703. doi: 10.1111/j.1365-2605.2008.00933.x. Epub 2008 Oct 30.

PMID:
19178596
29.

Risk factors for post-treatment hypogonadism in testicular cancer patients.

Eberhard J, Ståhl O, Cwikiel M, Cavallin-Ståhl E, Giwercman Y, Salmonson EC, Giwercman A.

Eur J Endocrinol. 2008 Apr;158(4):561-70. doi: 10.1530/EJE-07-0684.

30.

Narcisse: a mirror view of conserved syntenies.

Courcelle E, Beausse Y, Letort S, Stahl O, Fremez R, Ngom-Bru C, Gouzy J, Faraut T.

Nucleic Acids Res. 2008 Jan;36(Database issue):D485-90. Epub 2007 Nov 2.

31.

Sperm DNA integrity in testicular cancer patients.

Ståhl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Ståhl E, Giwercman A.

Hum Reprod. 2006 Dec;21(12):3199-205. Epub 2006 Aug 24.

PMID:
16931803
32.

The RsaI polymorphism in the estrogen receptor-beta gene is associated with male infertility.

Aschim EL, Giwercman A, Ståhl O, Eberhard J, Cwikiel M, Nordenskjöld A, Haugen TB, Grotmol T, Giwercman YL.

J Clin Endocrinol Metab. 2005 Sep;90(9):5343-8. Epub 2005 Jul 5.

PMID:
15998774
33.

Linkage between androgen receptor gene CAG trinucleotide repeat length and testicular germ cell cancer histological type and clinical stage.

Giwercman A, Lundin KB, Eberhard J, Ståhl O, Cwikiel M, Cavallin-Ståhl E, Giwercman YL.

Eur J Cancer. 2004 Sep;40(14):2152-8.

PMID:
15341991
34.

Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study.

Eberhard J, Ståhl O, Giwercman Y, Cwikiel M, Cavallin-Ståhl E, Lundin KB, Flodgren P, Giwercman A.

Hum Reprod. 2004 Jun;19(6):1418-25. Epub 2004 Apr 22.

PMID:
15105386
35.

The impact of testicular carcinoma and its treatment on sperm DNA integrity.

Ståhl O, Eberhard J, Jepson K, Spano M, Cwikiel M, Cavallin-Ståhl E, Giwercman A.

Cancer. 2004 Mar 15;100(6):1137-44.

36.

Protein accumulation and gene mutation of p53 in bilateral breast cancer. South-East Sweden Breast Cancer Group.

Stenmark-Askmalm M, Gentile M, Wingren S, Ståhl O.

Acta Oncol. 2001;40(1):56-62.

PMID:
11321662
37.

eta Carinae: Binarity Confirmed.

Damineli A, Kaufer A, Wolf B, Stahl O, Lopes DF, de Araújo FX.

Astrophys J. 2000 Jan 10;528(2):L101-L104.

PMID:
10600628

Supplemental Content

Support Center